Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003724
Filing Date
2021-11-09
Accepted
2021-11-09 16:01:28
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cycn-20210930.htm   iXBRL 10-Q 2160875
2 EX-31.1 cycn-ex31_1.htm EX-31.1 14174
3 EX-31.2 cycn-ex31_2.htm EX-31.2 14004
4 EX-32.1 cycn-ex32_1.htm EX-32.1 7941
5 EX-32.2 cycn-ex32_2.htm EX-32.2 7934
  Complete submission text file 0000950170-21-003724.txt   7149277

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cycn-20210930_cal.xml EX-101.CAL 39256
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cycn-20210930_pre.xml EX-101.PRE 281363
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cycn-20210930_def.xml EX-101.DEF 170264
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cycn-20210930_lab.xml EX-101.LAB 403937
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cycn-20210930.xsd EX-101.SCH 45588
11 EXTRACTED XBRL INSTANCE DOCUMENT cycn-20210930_htm.xml XML 1226139
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 211391936
SIC: 2834 Pharmaceutical Preparations